Johnson & Johnson was one of the first companies to devote large resources to the fight against COVID-19 and vaccine development, and was one of the first to receive support from the US government.<\/p>\n
However, J&J is not currently one of the companies, who conducting clinical trials of its final vaccine candidates COVID-19 in humans. Among others, the leaders are now companies such as Pfizer and BioNTech, Moderna.<\/p>\n
However, J&J is the world’s largest medical company with a huge resource, and its candidate for the COVID-19 vaccine, according to current data, has more privileges that can make it the biggest winner of all.<\/p>\n
Johnson & Johnson may offer only one dose for strong immunity<\/p>\n
J&J published on July 30 the results of a preclinical study of the leading candidate for the vaccine “Ad26.COV2-S”, on primates, they showed the formation of strong immune responses from the viral growths of high levels of neutralizing antibodies, which can be infected with coronavirus.<\/p>\n
Particularly optimistic is that a strong immune suppressor primates took after a single dose of vaccine. although the company plans to include both single and double dosing in their planned studies in humans, chances are that it can confirm the effectiveness of a single injection of the vaccine. Potentially it may be cheaper and acceptable for government vaccination programs.<\/p>\n
In addition to more potential priority of a single-dose approach, J&J also intends to charge a much lower fee for the vaccine than its main competitors.<\/p>\n
Last week, J&J signed a deal with the US government to supply 100 million doses of Ad26.COV2-S for about $ 1 billion. By comparison, Pfizer and BioNTech will ship 100 million doses to the United States almost twice as expensive – $ 1.9 billion.<\/p>\n
Lower prices with fewer doses may seem like an unwise strategy, however, experts are asking investors not to “write off J&J from the accounts” because, according to epidemiologists, COVID-19 can still “live” on our land for a long time. There is a high probability that vaccination against COVID-19 may be the same procedure as the traditional annual vaccination against influenza.<\/p>\n
In the current environment, while continuing pandemic, J & J, probably will sell it at cost. A disposable, inexpensive vaccine from a world-renowned company can be very attractive to governments around the world. This can create good publicity for the vaccine and the potential for sales at a higher price later when added to the traditional annual vaccination calendar.<\/p>\n
Investors will learn more about Johnson & Johnson’s Ad26.COV2-S vaccine in September, when the company moves to a later stage of the study.<\/p>\n","protected":false},"featured_media":122266,"menu_order":0,"template":"","newscat":[9],"newstag":[26196,26360,26898,24666,26260,26195,27547,27520,27521,24933,24936],"issues":[],"class_list":["post-122265","news","type-news","status-publish","has-post-thumbnail","hentry","newscat-novosti","newstag-biontech","newstag-coronavirus-pandemic","newstag-j-amp-j","newstag-johnson-amp-johnson","newstag-moderna","newstag-pfizer","newstag-vaccination-against-covid-19","newstag-vakczynaczyya-ot-covid-19","newstag-vakczynacziya-vid-covid-19","newstag-pandemyya-koronavyrusa","newstag-pandemiya-koronavirusu"],"_links":{"self":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/news\/122265","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/media\/122266"}],"wp:attachment":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/media?parent=122265"}],"wp:term":[{"taxonomy":"newscat","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/newscat?post=122265"},{"taxonomy":"newstag","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/newstag?post=122265"},{"taxonomy":"issues","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/issues?post=122265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}